Fortress Biotech (FBIO) Misses Q3 EPS by 72c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall St rises as oil falls heading into US midterm elections
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mail
Get Alerts FBIO Hot Sheet
Join SI Premium – FREE
Fortress Biotech (NASDAQ: FBIO) reported Q3 EPS of ($0.94), $0.72 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $34.75 million versus the consensus estimate of $14.28 million.
For earnings history and earnings-related data on Fortress Biotech (FBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley bearish on Coinbase, slashes target on weaker recovery
- Boeing shares rise after investment club buys the dip
- CoreWeave shares slip despite CrowdStrike partnership
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
